221 related articles for article (PubMed ID: 27593870)
1. Clinical Efficacy of Subcutaneous Allergen Immunotherapy in Patients with Atopic Dermatitis.
Nahm DH; Kim ME; Kwon B; Cho SM; Ahn A
Yonsei Med J; 2016 Nov; 57(6):1420-6. PubMed ID: 27593870
[TBL] [Abstract][Full Text] [Related]
2. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis.
Zhou J; Chen S; Song Z
Allergy Asthma Proc; 2021 Mar; 42(2):e47-e54. PubMed ID: 33685566
[No Abstract] [Full Text] [Related]
4. Effect of Cluster Allergen-Specific Immunotherapy in Patients with Atopic Dermatitis Sensitive to House Dust Mite.
Elazab SZ; Hessam WF; Gomaa AH
Egypt J Immunol; 2018 Jun; 25(2):97-106. PubMed ID: 30600952
[TBL] [Abstract][Full Text] [Related]
5. Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE-Blocking Factors for Three Mite Subcutaneous Immunotherapy Products.
Park KH; Lee SC; Son YW; Jeong KY; Shin YS; Shin JU; Sim da W; Park HJ; Lee JH; Lee KH; Park JW
Yonsei Med J; 2016 Nov; 57(6):1427-34. PubMed ID: 27593871
[TBL] [Abstract][Full Text] [Related]
6. Treatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin.
Nahm DH; Kim ME
Yonsei Med J; 2012 Jan; 53(1):158-63. PubMed ID: 22187247
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Analysis on the Effects of House Dust Mite Specific Immunotherapy for More Than 3 Years in Atopic Dermatitis.
Lee J; Lee H; Noh S; Bae BG; Shin JU; Park CO; Lee KH
Yonsei Med J; 2016 Mar; 57(2):393-8. PubMed ID: 26847292
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.
Cadario G; Galluccio AG; Pezza M; Appino A; Milani M; Pecora S; Mastrandrea F
Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996
[TBL] [Abstract][Full Text] [Related]
9. Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite.
Zhong H; Deng X; Song Z; Darsow U; Chen W; Chen S; Luo N; Hao F
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1318-24. PubMed ID: 25376542
[TBL] [Abstract][Full Text] [Related]
10. Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis.
Kim ME; Kim JE; Sung JM; Lee JW; Choi GS; Nahm DH
J Korean Med Sci; 2011 Sep; 26(9):1159-64. PubMed ID: 21935270
[TBL] [Abstract][Full Text] [Related]
11. Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects.
Chaoul N; Albanesi M; Giliberti L; Rossi MP; Nettis E; Di Bona D; Caiaffa MF; Macchia L
Int Arch Allergy Immunol; 2019; 179(1):37-42. PubMed ID: 30921804
[TBL] [Abstract][Full Text] [Related]
12. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis?
Bussmann C; Böckenhoff A; Henke H; Werfel T; Novak N
J Allergy Clin Immunol; 2006 Dec; 118(6):1292-8. PubMed ID: 17157659
[TBL] [Abstract][Full Text] [Related]
13. Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
Yepes-Nuñez JJ; Guyatt GH; Gómez-Escobar LG; Pérez-Herrera LC; Chu AWL; Ceccaci R; Acosta-Madiedo AS; Wen A; Moreno-López S; MacDonald M; Barrios M; Chu X; Islam N; Gao Y; Wong MM; Couban R; Garcia E; Chapman E; Oykhman P; Chen L; Winders T; Asiniwasis RN; Boguniewicz M; De Benedetto A; Ellison K; Frazier WT; Greenhawt M; Huynh J; Kim E; LeBovidge J; Lind ML; Lio P; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel J; Wang J; Wheeler KE; Schneider L; Chu DK
J Allergy Clin Immunol; 2023 Jan; 151(1):147-158. PubMed ID: 36191689
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis.
Novak N; Bieber T; Hoffmann M; Fölster-Holst R; Homey B; Werfel T; Sager A; Zuberbier T
J Allergy Clin Immunol; 2012 Oct; 130(4):925-31.e4. PubMed ID: 22947344
[TBL] [Abstract][Full Text] [Related]
16. Allergen-specific immunotherapy for patients with atopic dermatitis sensitized to animal dander.
Chu H; Park KH; Kim SM; Lee JH; Park JW; Lee KH; Park CO
Immun Inflamm Dis; 2020 Jun; 8(2):165-169. PubMed ID: 32162849
[TBL] [Abstract][Full Text] [Related]
17. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
[TBL] [Abstract][Full Text] [Related]
19. The Effectiveness of Allergen Immunotherapy in Adult Patients with Atopic Dermatitis Allergic to House Dust Mites.
Bogacz-Piaseczyńska A; Bożek A
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676639
[TBL] [Abstract][Full Text] [Related]
20. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex.
Nahm DH; Lee ES; Park HJ; Kim HA; Choi GS; Jeon SY
Int Arch Allergy Immunol; 2008; 146(3):235-40. PubMed ID: 18268392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
